[Assessment of visual acuity in patients with age-related macular degeneration 1 year after photodynamic therapy]
Related Experiment Video
Updated: Jun 11, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
1Department of Ophthalmology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan. usa0@hotmail.com
Purpose:
To evaluate visual acuity in patients who underwent photodynamic therapy (PDT) for exudative age-related macular degeneration (AMD).
Methods:
138 eyes undergoing PDT were studied retrospectively. 101 eyes with AMD (AMD group) and 37 eyes with polypoidal choroidal vasculopathy (PCV group) were evaluated.
Results:
In the AMD group, one year after PDT, the log MAR visual acuity improved by 2 lines or more in 23 eyes (22.8%), and decreased by 2 lines or more in 27 eyes (26.7%). In the PCV group, one year after PDT the log MAR visual acuity improved by 2 lines or more in 13 eyes (35.1%), and decreased by 2 lines or more in 8 eyes (21.6%). Out of the 138 eyes, 30 eyes showed improvement in visual acuity by 0.6 or more, one year after PDT (AMD group : 17 eyes; PCV group: 13 eyes)
Conclusions:
Patients with PCV who had good primary visual acuity improved their visual acuity by 0.6 or more one year after PDT.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Diabetic Retinopathy